Nigeria, Kenya, Lesotho, South Sudan, Burkina Faso and Mali - as well as Haiti and Ukraine - would run out of live-saving ...

Mr Ghebreyesus said the countries which includes Haiti, Kenya, Lesotho, South Sudan, Burkina Faso, Mali, Nigeria, and Ukraine ...

WHO Director-General Tedros Adhanom Ghebreyesus said that disruptions “could undo 20 years of progress” on HIV.

The HIV Drugs Market is expected to grow steadily from 2025 to 2035, driven by advancements in antiretroviral therapy and increasing global awareness initiatives. Rising HIV prevalence, improved ...

The CDC's $1.3 billion Division of HIV Prevention is tasked with tracking infections across the United States.

Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...

Seven weeks into US President Donald Trump’s suspension of foreign aid, including funds for HIV/ AIDS treatment, panic has gripped persons living with the virus as they cannot access the required ...

Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...

PrEP是一种药物治疗方案，通过阻止病毒进入人体细胞和在人体细胞中复制，从而预防高危人群感染HIV。目前，PrEP药物被推荐为每日口服或每隔一月注射一次。 如果正确采用此方案，PrEP预防HIV的有效性将超过90% 。然而，在2023年，本应从PrEP中受益的2120万人中只有350万人接受了治疗 [2] ， 这凸显了通过例如选择长效PrEP等方式消除现有障碍的必要性 ...

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

The U.S. health department is currently evaluating the CDC's HIV Prevention Division for potential overlaps with other ...

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...